In the wake of the 2018 midterm elections — which handed Democrats control of the House of Representatives — President Trump said he hoped to work with lawmakers on the other side of the aisle to lower the cost of prescription drugs. Some industry analysts, though, are skeptical that sentiment will be enough to enact meaningful change, at least on the legislative front.
- People on the Move
- Medicare and Medicaid
- Datapoint, Medicare and Medicaid
- Abstract, Health Plans
- Datapoint, Drug Benefits, Medicare and Medicaid